Company news
bioAffinity Technologies, Inc. news in 2023
bioAffinity Technologies, Inc.'s news releases, calls and decks from 2023, newest first.
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
December 4, 2023
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
November 13, 2023
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
November 5, 2023
bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services
September 18, 2023
bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update
August 13, 2023
bioAffinity Technologies Reports First Quarter 2023 Financial Results
May 14, 2023
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
April 30, 2023
bioAffinity Technologies to Ring Nasdaq Closing Bell Today
April 4, 2023
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
March 30, 2023
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
March 27, 2023
bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
March 23, 2023
bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications
February 12, 2023
bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research
January 23, 2023
bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments
January 3, 2023
Calls in 2023
Decks in 2023
- 8th Annual Dawson James Small Cap Growth Conference 2023
Conference · 16 slides · Oct 10, 2023